Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose NNC 0142-0000-0002 in active rheumatoid arthritis on methotrexate
2010-019261-28Phase 2Completed
- Sponsor
- Novo Nordisk
- Start
- Jun 2010
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in rheumatoid arthritis (RA) comparing NNC 0142-0000-0002 + background methotrexate with Placebo + background methotrexate (2 arms). Primary endpoint: Change in DAS28-CRP from baseline to Week 12. Started Jun 2010; status: completed.
02
Drugs
NNC0142-0002
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2010-019261-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019261-28.